Condition
Lymphangioleiomyomatosis (LAM) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Lymphangioleiomyomatosis (LAM) clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), United States (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Blood extracellular vesicles as markers of lung involvement in LAM and TSC.
We will test whether blood extracellular vesicles can show lung involvement in adults with LAM or tuberous sclerosis complex.
-
Long-term safety of Imatinib for patients with Lymphangioleiomyomatosis
This study is testing if the cancer drug Imatinib is safe and can help women with Lymphangioleiomyomatosis by seeing how it affects their lung health over time.
Related topics
Quick answers
How many Lymphangioleiomyomatosis (LAM) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.